# Qilu Antibiotics Pharmaceutical Co. , Ltd. – FDA Inspection, May 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/8aa0dc2a-11f5-467c-8d7a-3d6b0a405998
Source feed: FDA_Inspections

> FDA inspection 1210065 of Qilu Antibiotics Pharmaceutical Co. , Ltd., May 30, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1210065
- Company Name: Qilu Antibiotics Pharmaceutical Co. , Ltd.
- Inspection Date: 2023-05-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1333262 - 2026-07-16](https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/7d9d4743-875c-4992-a37a-35fe116bf9bf)
- [FDA Inspection 1067678 - 2018-08-16](https://www.keypedia.com/records/fda_inspections/qilu-antibiotics-pharmaceutical-co-ltd/3c041f5a-2a6c-4c99-8b5b-11e9ce5a735c)
- FDA Inspection 945452 - 2015-09-22
- FDA Inspection 851836 - 2013-09-20

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/cynthia-jim/e0f1c8a7-d787-442a-911c-61e37cd806a6)
- [FDA Associated Person](https://www.keypedia.com/people/suzanne-n-vallez/7c16e0f4-c0b1-4f50-adfa-b1dc534694cd)

Company: https://www.keypedia.com/companies/qilu-antibiotics-pharmaceutical-co-ltd/f1c696c7-317f-4fb9-92a1-df8381af004c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c